DJIA 17,191.37 -195.84 -1.13%
NASDAQ 4,637.99 -43.50 -0.93%
S&P 500 2,002.16 -27.39 -1.35%
market minute promo

Prosensa Holding B.V. (NASDAQ: RNA)

18.73 -0.06 (-0.32%)

Quote as of

Extended Hours: $18.72 -$0.01 (-0.06%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

RNA $18.73 -0.32%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $18.80
Previous Close $18.79
Daily Range $18.66 - $18.80
52-Week Range $4.12 - $22.80
Market Cap $676.5M
P/E Ratio 0.00
Dividend (Yield) $0.00 (0.0%)
Volume 49,138
Average Daily Volume 230,154
Current FY EPS -$0.76

Sector

Industry

Prosensa Holding B.V. (RNA) Description

Prosensa Holding B.V. Website: http://www.prosensa.eu/

News & Commentary

3 Warning Signs You've Invested in a Dangerous Biotech Stock

Three Motley Fool analysts help investors spot biotech stock warning signals.

BioMarin to Raise Funds to Finance Prosensa Acquisition - Analyst Blog

State Of The Union Lights Up Biotech

Health Care Sector Update for 01/15/2015: NVGN,BMRN,RNA,TNXP

Health Care Sector Update for 01/15/2015: FLMN, FMS, BMRN, TNXP, RNA

Update: BioMarin To Acquire Prosensa Holding N.V.

BioMarin Gains on Vimizim 2014 View, Batten Disease Data - Analyst Blog

Sarepta Updates Eteplirsen Study Results, FDA Filing Still on for Mid Year

Why Sarepta Therapeutics Inc. Stock Tumbled 15% in December

Sarepta Therapeutics slumped by a double-digit percentage in December. Find out what's behind the move and whether or not shares are a bargain after their tumble.

BioMarin's Vimizim OK'd in Japan for Morquio A Syndrome - Analyst Blog

BioMarin's Vimizim OK'd in Japan for Morquio A Syndrome - Analyst Blog

See More RNA News...